Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Vocational evaluation and vocational guidance for young people with a history of drug abuse.

Siu AMH, Fung MSM, Cheung PPP, Shea CK, Lau BWM.

Work. 2019;62(2):327-336. doi: 10.3233/WOR-192867.

2.

Field evaluation of a PCR test for Schistosoma japonicum egg detection in low-prevalence regions of China.

Fung MS, Xiao N, Wang S, Carlton EJ.

Am J Trop Med Hyg. 2012 Dec;87(6):1053-8. doi: 10.4269/ajtmh.2012.12-0177. Epub 2012 Oct 29.

3.

Body image and eating attitudes among adolescent Chinese girls in Hong Kong.

Fung MS, Yuen M.

Percept Mot Skills. 2003 Feb;96(1):57-66.

PMID:
12705511
5.
6.

The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system.

Tanhehco EJ, Kilgore KS, Liff DA, Murphy KL, Fung MS, Sun WN, Sun C, Lucchesi BR.

Transplant Proc. 1999 Aug;31(5):2168-71. No abstract available.

PMID:
10456004
8.

Involvement of the complement system in antibody-mediated post-exposure protection against human immunodeficiency virus type 1.

Gauduin MC, Weir R, Fung MS, Koup RA.

AIDS Res Hum Retroviruses. 1998 Feb 10;14(3):205-11.

PMID:
9491910
9.

Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.

Jagodzinski PP, Wustner J, Kmieciak D, Wasik TJ, Fertala A, Sieron AL, Takahashi M, Tsuji T, Mimura T, Fung MS, Gorny MK, Kloczewiak M, Kaneko Y, Kozbor D.

Virology. 1996 Dec 15;226(2):217-27.

10.

Human IgA monoclonal antibodies specific for a major ragweed pollen antigen.

Sun LK, Fung MS, Sun WN, Sun CR, Chang WI, Chang TW.

Biotechnology (N Y). 1995 Aug;13(8):779-86.

PMID:
9634808
11.

Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody.

Gauduin MC, Safrit JT, Weir R, Fung MS, Koup RA.

J Infect Dis. 1995 May;171(5):1203-9.

PMID:
7751695
12.

A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120.

Günthard HF, Gowland PL, Schüpbach J, Fung MS, Böni J, Liou RS, Chang NT, Grob P, Graepel P, Braun DG, et al.

J Infect Dis. 1994 Dec;170(6):1384-93.

PMID:
7995976
13.

Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.

Major JG, Liou RS, Sun LK, Yu LM, Starnes SM, Fung MS, Chang TW, Chang NT.

Hum Antibodies Hybridomas. 1994;5(1-2):9-17.

PMID:
7858187
14.

Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.

Moore JP, Sattentau QJ, Yoshiyama H, Thali M, Charles M, Sullivan N, Poon SW, Fung MS, Traincard F, Pinkus M, et al.

J Virol. 1993 Oct;67(10):6136-51.

15.
16.

Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 disease.

Schüpbach J, Günthard H, Fung MS, Liou RS, Botta L, Gowland P, Gordon W, Gygax D, Chang NT, Chang TW, et al.

Biotherapy. 1993;6(3):205-15.

PMID:
8292461
17.

Potential utility of passive immunization in preventing vertical HIV-1 transmission.

Braun DG, Fung MS, Chang NT, Chang TW.

Immunodeficiency. 1993;4(1-4):349-51. Review. No abstract available.

PMID:
8167729
18.
19.

Discontinuous epitopes on gp120 important in HIV-1 neutralization.

Ho DD, Fung MS, Yoshiyama H, Cao Y, Robinson JE.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1337-9. No abstract available.

PMID:
1281654
20.

Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120.

Fung MS, Sun CR, Gordon WL, Liou RS, Chang TW, Sun WN, Daar ES, Ho DD.

J Virol. 1992 Feb;66(2):848-56.

21.

Mouse/human chimeric anti-HIV-1 gp120 antibody to the principal neutralizing determinant: tolerability and pharmacokinetics in cynomolgus monkeys, Macaca fascicularis.

Liou RS, Fung MS, Zühlke U, Gudat F, McKinney S, Gordon W, Bee W, Botta L, Gygax D, Chang TW, et al.

Biotherapy. 1992;5(4):291-9.

PMID:
1283953
22.
23.

Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.

Fung MS, Sun CR, Liou RS, Gordon W, Chang NT, Chang TW, Sun NC.

J Immunol. 1990 Oct 1;145(7):2199-206.

PMID:
2398276
24.

Immunoconjugates that neutralize HIV virions kill T cells infected with diverse strains of HIV-1.

Kim YW, Fung MS, Sun NC, Sun CR, Chang NT, Chang TW.

J Immunol. 1990 Feb 15;144(4):1257-62.

PMID:
2303707
25.

A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells.

Liou RS, Rosen EM, Fung MS, Sun WN, Sun C, Gordon W, Chang NT, Chang TW.

J Immunol. 1989 Dec 15;143(12):3967-75.

PMID:
2480382
26.

Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120.

Sun NC, Ho DD, Sun CR, Liou RS, Gordon W, Fung MS, Li XL, Ting RC, Lee TH, Chang NT, et al.

J Virol. 1989 Sep;63(9):3579-85.

Supplemental Content

Support Center